STAT+: Lilly’s weekly insulin works as well as daily products, new studies show
Eli Lilly reported Thursday that its experimental weekly insulin worked as well as daily basal insulin products in two late-stage studies, paving the way for the drug to compete with a similar weekly insulin developed by Novo Nordisk. In a 52-week